About-Us_Hero0.jpg

Executive Team

Under the leadership of Chief Executive Officer, Mr. Enrique Conterno FibroGen’s executive team includes accomplished leaders with deep and broad experience. Supported by a staff of approximately 600 employees worldwide, we are focused on delivering first-in-class medicines for the treatment of unmet medical needs.
Enrique-Aug21-230x230.jpg
Enrique Conterno

Chief Executive Officer

Kirk-Aug21-230x230.jpg
Kirk Christoffersen

Chief Business Officer

Chris-Portrait-Feb22-230x230.jpg
Christine L. Chung

Senior Vice President,
China Operations

Eisner-230x230-Feb21.jpg
Mark Eisner, M.D.,
M.P.H.

Chief Medical Officer

Juan-Aug21-230x230.jpg
Juan Graham

Chief Financial Officer

hunter-no-tie-Feb22-v1_edited.jpg
John Hunter, Ph.D.

Chief Scientific Officer

Michael-D.-Lowenstein-JD.jpg
Michael D. Lowenstein,
J.D.

Chief Legal Officer

Leanne-C.-Price-JD.jpg
Leanne C. Price, J.D.

Chief Intellectual
Property Officer

Tricia_stewart.jpg
Tricia Stewart

Chief People Officer

wettig-no-tie-Feb22-v1_edited.jpg
Thane Wettig

Chief Commercial Officer

Blue_bar_icon.png

Our Leadership

We are putting substantial expertise to work in
developing and commercializing novel therapeutics.